Eltabeeb, M. A., Hamed, R. R., El-Nabarawi, M. A., Teaima, M. H., Hamed, M. I. A., Darwish, K. M., . . . Abdellatif, M. M. (2025). Nanocomposite alginate hydrogel loaded with propranolol hydrochloride kolliphor® based cerosomes as a repurposed platform for Methicillin-Resistant Staphylococcus aureus-(MRSA)-induced skin infection; in-vitro, ex-vivo, in-silico, and in-vivo evaluation. Drug Delivery and Translational Research: An Official Journal of the Controlled Release Society, 15(2), 556-576. https://doi.org/10.1007/s13346-024-01611-z
Chicago Style (17th ed.) CitationEltabeeb, Moaz A., Raghda Rabe Hamed, Mohamed A. El-Nabarawi, Mahmoud H. Teaima, Mohammed I. A. Hamed, Khaled M. Darwish, Mariam Hassan, and Menna M. Abdellatif. "Nanocomposite Alginate Hydrogel Loaded with Propranolol Hydrochloride Kolliphor® Based Cerosomes as a Repurposed Platform for Methicillin-Resistant Staphylococcus Aureus-(MRSA)-induced Skin Infection; In-vitro, Ex-vivo, In-silico, and In-vivo Evaluation." Drug Delivery and Translational Research: An Official Journal of the Controlled Release Society 15, no. 2 (2025): 556-576. https://doi.org/10.1007/s13346-024-01611-z.
MLA (9th ed.) CitationEltabeeb, Moaz A., et al. "Nanocomposite Alginate Hydrogel Loaded with Propranolol Hydrochloride Kolliphor® Based Cerosomes as a Repurposed Platform for Methicillin-Resistant Staphylococcus Aureus-(MRSA)-induced Skin Infection; In-vitro, Ex-vivo, In-silico, and In-vivo Evaluation." Drug Delivery and Translational Research: An Official Journal of the Controlled Release Society, vol. 15, no. 2, 2025, pp. 556-576, https://doi.org/10.1007/s13346-024-01611-z.